Park Ha Biological Tech Files 6-K, Announces EGM
Ticker: BYAH · Form: 6-K · Filed: Nov 28, 2025 · CIK: 1986247
Sentiment: neutral
Topics: reporting, foreign-private-issuer, agm
TL;DR
Park Ha Bio Tech (PHBT) filed a 6-K, confirming 20-F filings and noting an upcoming EGM.
AI Summary
Park Ha Biological Technology Co., Ltd. filed a Form 6-K on November 28, 2025, reporting on its activities for November 2025. The filing indicates the company is a foreign private issuer and will file its annual reports under Form 20-F. It also mentions an upcoming Extraordinary General Meeting.
Why It Matters
This filing provides an update on the company's reporting status and signals upcoming corporate actions like an Extraordinary General Meeting, which could involve significant shareholder decisions.
Risk Assessment
Risk Level: low — The filing is a routine report and does not contain specific financial or operational news that would immediately impact risk.
Key Players & Entities
- Park Ha Biological Technology Co., Ltd. (company) — Registrant
- 20251128 (date) — Filing Date
- Form 6-K (document) — Filing Type
- Form 20-F (document) — Annual Report Form
FAQ
What is the primary purpose of this Form 6-K filing?
This Form 6-K is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of November 2025.
Which form will Park Ha Biological Technology Co., Ltd. use for its annual reports?
The registrant indicates it files or will file annual reports under cover of Form 20-F.
When was this Form 6-K filed?
The filing was conformed as of November 28, 2025.
What is the company's principal executive office address?
The principal executive office is located at 901, Building C Phase 2, Wuxi International Life Science Innovation Campus, 196 Jinghui East Road, Xinwu District, Wuxi, Jiangsu Province, People's Republic of China 214000.
What significant event is mentioned in the filing?
The filing mentions a '2025 Extraordinary General Meeting'.
Filing Stats: 248 words · 1 min read · ~1 pages · Grade level 13.2 · Accepted 2025-11-28 16:06:19
Filing Documents
- ea0266568-01.htm (6-K) — 29KB
- ea026656801ex99-1_parkha.htm (EX-99.1) — 139KB
- ea026656801ex99-2_parkha.htm (EX-99.2) — 56KB
- 0001213900-25-116083.txt ( ) — 225KB
From the Filing
REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________ FORM 6-K _______________ REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2025 _______________ Park Ha Biological Technology Co., Ltd. (Exact name of registrant as specified in its charter) _______________ 901, Building C Phase 2, Wuxi International Life Science Innovation Campus 196 Jinghui East Road Xinwu District, Wuxi, Jiangsu Province People’s Republic of China 214000 (Address of Principal Executive Office) _______________ Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20 -F or Form 40 -F . Form 20 -F             Form 40 -F   2025 Extraordinary General Meeting In connection with the 2025 extraordinary general meeting of Park Ha Biological Technology Co., Ltd., a Cayman Islands company (the “ Company ”), the Company hereby furnishes the following documents: Exhibits Exhibit No.   Description 99.1   Notice of 2025 Extraordinary General Meeting, dated November 28, 2025, to be mailed to the shareholders of the Company 99.2   Form of Proxy Card to be mailed to the shareholders of the Company 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: November 28, 2025   Park Ha Biological Technology Co., Ltd.     By:   / s / ZHANG Xiaoqiu     Name:   ZHANG Xiaoqiu     Title:   Chief Executive Officer and Chairperson of the Board 2